Search Results - "Indolfi, Laura"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    The role of scaffold microarchitecture in engineering endothelial cell immunomodulation by Indolfi, Laura, Baker, Aaron B, Edelman, Elazer R

    Published in Biomaterials (01-10-2012)
    “…Abstract The implantation of matrix-embedded endothelial cells (MEECs) has been reported to have great therapeutic potential in controlling the vascular…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Coating process and early stage adhesion evaluation of poly(2-hydroxy-ethyl-methacrylate) hydrogel coating of 316L steel surface for stent applications by Indolfi, Laura, Causa, Filippo, Netti, Paolo Antonio

    “…In this study, a spray-coating method has been set up with the aim to control the coating of poly(2-hydroxy-ethyl-methacrylate) (pHEMA), an hydrophilic…”
    Get full text
    Journal Article
  4. 4

    Microsphere-integrated drug-eluting stents: PLGA microsphere integration in hydrogel coating for local and prolonged delivery of hydrophilic antirestenosis agents by Indolfi, Laura, Causa, Filippo, Giovino, Concetta, Ungaro, Francesca, Quaglia, Fabiana, Netti, Paolo Antonio

    “…The development of a novel generation of drug‐eluting stent (DES) relies upon the idea to obtain very flexible platforms able to overcome some issues…”
    Get full text
    Journal Article
  5. 5

    Tubular bridges for bronchial epithelial cell migration and communication by Zani, Brett G, Indolfi, Laura, Edelman, Elazer R

    Published in PloS one (28-01-2010)
    “…Biological processes from embryogenesis to tumorigenesis rely on the coordinated coalescence of cells and synchronized cell-to-cell communication…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Phase I study of PTM-101 as neoadjuvant therapy for borderline resectable or locally advanced pancreatic ductal adenocarcinoma: A trial in progress by Pilgrim, Charles, Smith, Marty, Ban, Jun, Ellis, Sam, Zalcberg, John Raymond, Markman, Ben, Lashof-Sullivan, Margaret, Indolfi, Laura

    Published in Journal of clinical oncology (01-02-2023)
    “…TPS775 Background: While there have been tremendous advances in cancer treatment, critical challenges remain including limited ability of drugs to successfully…”
    Get full text
    Journal Article
  8. 8

    Novel targeted and sustained drug delivery therapy for localized pancreatic cancer: Validation in porcine models and minimally invasive surgical feasibility in human cadavers by Lashof-Sullivan, Margaret, Kim, Michael Paul, Tzeng, Ching-Wei David, Indolfi, Laura

    Published in Journal of clinical oncology (20-05-2020)
    “…Abstract only e16747 Background: As systemic therapy improves, control of localized pancreatic adenocarcinoma (PDAC) remains a major challenge. Up to 40% of…”
    Get full text
    Journal Article
  9. 9

    Abstract B26: Targeted and sustained drug delivery therapy for localized pancreatic cancer: In vivo validation in porcine models by Lashof-Sullivan, Margaret, McSweeney, Amanda L., Ting, David T., Kim, Michael P., Tzeng, Ching-Wei D., Indolfi, Laura

    Published in Cancer research (Chicago, Ill.) (15-12-2019)
    “…Abstract As systemic therapy improves, local control of nonmetastatic pancreatic adenocarcinoma (PDAC) remains a major challenge. Up to 40% of patients present…”
    Get full text
    Journal Article
  10. 10

    Abstract 2393: Development of a novel implantable drug-eluting product for the local treatment of pancreatic adenocarcinoma by Lashof-Sullivan, Margaret, Sloan, Leslie S., Kim, Michael P., Indolfi, Laura, Tzeng, Ching-Wei D.

    Published in Cancer research (Chicago, Ill.) (22-03-2024)
    “…Abstract Background Local control of non-metastatic pancreatic ductal adenocarcinoma (PDAC) remains a major challenge. Therapies with reduced systemic toxicity…”
    Get full text
    Journal Article
  11. 11

    Abstract CT106: First-in-human phase 1 study of paclitaxel-eluting PTM-101 film in subjects with borderline resectable or locally advanced pancreatic cancers by Pilgrim, Charles, Smith, Marty, Ban, Ee-Jun, Ellis, Samantha, Zalcberg, John, Markman, Benjamin, Lashof-Sullivan, Margaret, Indolfi, Laura

    Published in Cancer research (Chicago, Ill.) (05-04-2024)
    “…Abstract Background Unlike many other types of cancer, improvements in the treatment of pancreatic cancer have been very limited, in part due to the inability…”
    Get full text
    Journal Article
  12. 12

    A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma by Indolfi, Laura, Ligorio, Matteo, Ting, David T, Xega, Kristina, Tzafriri, Abraham R, Bersani, Francesca, Aceto, Nicola, Thapar, Vishal, Fuchs, Bryan C, Deshpande, Vikram, Baker, Aaron B, Ferrone, Cristina R, Haber, Daniel A, Langer, Robert, Clark, Jeffrey W, Edelman, Elazer R

    Published in Biomaterials (01-07-2016)
    “…Abstract Pancreatic ductal adenocarcinoma (PDAC) is one of the most devastating and painful cancers. It is often highly resistant to therapy owing to inherent…”
    Get full text
    Journal Article
  13. 13

    Microsphere-integrated collagen scaffolds for tissue engineering: Effect of microsphere formulation and scaffold properties on protein release kinetics by Ungaro, Francesca, Biondi, Marco, d'Angelo, Ivana, Indolfi, Laura, Quaglia, Fabiana, Netti, Paolo Antonio, La Rotonda, Maria Immacolata

    Published in Journal of controlled release (28-06-2006)
    “…A promising approach to control the time and space distribution of signalling molecules inside tissue engineering scaffolds consists in entrapping…”
    Get full text
    Journal Article
  14. 14

    Abstract 4584: A novel drug-eluting platform for localized treatment of pancreatic cancer by Ligorio, Matteo, Indolfi, Laura, Ting, David T., Xega, Kristina, Aceto, Nicola, Bersani, Francesca, Ferrone, Cristina R., Haber, Daniel A., Langer, Robert, Edelman, Elazer R., Clark, Jeffrey W.

    Published in Cancer research (Chicago, Ill.) (01-10-2014)
    “…Abstract INTRODUCTION. The majority of patients with pancreatic ductal adenocarcinoma (PDAC) succumb to the disease within 12-24 months from their diagnosis…”
    Get full text
    Journal Article
  15. 15

    Abstract 75: Heparanase Mediates Arteriothrombosis Following Vascular Injury or Endovascular Stenting by Baker, Aaron, Gibson, William, Kolachalama, Vijaya, Golomb, Mordechai, Indolfi, Laura, Spruell, Christopher, Zcharia, Eyal, Vlodavsky, Israel, Edelman, Elazer

    “…Abstract only Background: Heparanase cleaves heparan sulfate proteoglycans (HSPGs), key components of the extracellular matrix and critical endothelial…”
    Get full text
    Journal Article
  16. 16

    Bioactivated collagen-based scaffolds embedding protein-releasing biodegradable microspheres: tuning of protein release kinetics by Biondi, Marco, Indolfi, Laura, Ungaro, Francesca, Quaglia, Fabiana, La Rotonda, Maria Immacolata, Netti, Paolo A.

    “…In tissue engineering, the recapitulation of natural sequences of signaling molecules, such as growth factors, as occurring in the native extracellular matrix…”
    Get full text
    Journal Article
  17. 17

    Abstract 5481: Heparanase Regulates the Thrombotic Potential of Vascular Injury and Stent Placement by Baker, Aaron, Gibson, William, Kolachalama, Vijaya B, Golumb, Mordachai, Indolfi, Laura, Edelman, Elazer R

    Published in Circulation (New York, N.Y.) (03-11-2009)
    “…Abstract only Background: Heparanase cleaves heparan sulfate proteoglycans (HSPGs), key components of the extracellular matrix and critical endothelial…”
    Get full text
    Journal Article
  18. 18

    Matrix-embedded endothelial cells are protected from the uremic milieu by Chitalia, Vipul C., Murikipudi, Sylaja, Indolfi, Laura, Rabadi, Laith, Valdez, Rachel, Franses, Joseph W., Edelman, Elazer R.

    Published in Nephrology, dialysis, transplantation (01-12-2011)
    “…Background. Endothelial cells (ECs) embedded in 3D matrices [matrix-embedded endothelial cells (MEECs)] of denatured collagen implanted around vascular access…”
    Get full text
    Journal Article